CurevacNL0015436031CVACCVAC
Curevac
NL0015436031
CVAC
CVAC
Financials
Market Cap
$562.05M5Y beta
2.52EPS (TTM)
-$1.483Free Float
122.20MRevenue (TTM)
$45.87MEBITDA (TTM)
-$308.12MFree Cashflow (TTM)
-$358.16MPricing
1D span
$2.264$2.371
52W span
$2.215$12.36
Analyst Ratings
The price target is $13.30 and the stock is covered by 9 analysts.
Buy
6
Hold
2
Sell
1
Information
1049Biotechnology & DrugsHealth Care
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
Identifier
ISIN
NL0015436031
Primary Ticker
CVAC